Insider Trades57 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Buy | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 38,110 | $8.66 | $6.7B | -0.05% | +140.43% | $330.0K | +21.60% | — | Stalk |
| Mar 17, 2026 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 5,000 | $114.52 | $6.7B | -0.05% | +140.43% | $572.6K | -14.73% | — | Stalk |
| Mar 4, 2026 | Sell | ACLX | Rami Elghandour | — | 101,164 | $114.30 | $6.7B | -0.05% | +140.43% | $11.6M | -36.65% | — | Stalk |
| Feb 27, 2026 | Sell | ACLX | Rami Elghandour | — | 89,916 | $113.92 | $6.7B | -0.05% | +140.43% | $10.2M | -24.57% | — | Stalk |
| Feb 25, 2026 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 11,219 | $113.82 | $6.7B | -0.05% | +140.43% | $1.3M | -24.84% | — | Stalk |
| Feb 19, 2026 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 8,384 | $68.29 | $6.7B | -0.05% | +140.43% | $572.6K | -5.61% | — | Stalk |
| Feb 17, 2026 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 11,291 | $69.51 | $6.7B | -0.05% | +140.43% | $784.8K | -9.22% | — | Stalk |
| Feb 11, 2026 | Sell | ACLX | Rami Elghandour | — | 198,000 | $69.88 | $6.7B | -0.05% | +140.43% | $13.8M | -35.11% | — | Stalk |
| Feb 11, 2026 | Sell | ACLX | Rami Elghandour | — | 218,500 | $69.88 | $6.7B | -0.05% | +140.43% | $15.3M | -27.92% | — | Stalk |
| Jan 14, 2026 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 5,882 | $68.51 | $6.7B | -0.05% | +140.43% | $403.0K | -19.85% | — | Stalk |
| Jan 13, 2026 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 7,437 | $65.51 | $6.7B | -0.05% | +140.43% | $487.2K | -20.06% | — | Stalk |
| Jan 12, 2026 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 6,131 | $64.15 | $6.7B | -0.05% | +140.43% | $393.3K | -14.19% | — | Stalk |
| Nov 17, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 340 | $90.00 | $6.7B | -0.05% | +140.43% | $30.6K | -54.49% | 10b5-1 | Stalk |
| Oct 15, 2025 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 5,364 | $91.04 | $6.7B | -0.05% | +140.43% | $488.3K | -38.79% | 10b5-1 | Stalk |
| Oct 3, 2025 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 5,946 | $86.04 | $6.7B | -0.05% | +140.43% | $511.6K | -17.15% | 10b5-1 | Stalk |
| Sep 30, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 21,034 | $81.28 | $6.7B | -0.05% | +140.43% | $1.7M | -52.36% | 10b5-1 | Stalk |
| Sep 29, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 73 | $80.16 | $6.7B | -0.05% | +140.43% | $5.9K | -0.34% | 10b5-1 | Stalk |
| Sep 26, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 12,396 | $80.12 | $6.7B | -0.05% | +140.43% | $993.2K | -36.32% | 10b5-1 | Stalk |
| Sep 18, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 3,643 | $80.01 | $6.7B | -0.05% | +140.43% | $291.5K | -5.05% | 10b5-1 | Stalk |
| Aug 28, 2025 | Sell | ACLX | Rami Elghandour | — | 546,938 | $70.25 | $6.7B | -0.05% | +140.43% | $38.4M | -46.95% | — | Stalk |
| May 27, 2025 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 12,235 | $64.14 | $6.7B | -0.05% | +140.43% | $784.8K | -20.31% | — | Stalk |
| Feb 26, 2025 | Sell | ACLX | Rami Elghandour | — | 38,300 | $62.02 | $6.7B | -0.05% | +140.43% | $2.4M | -7.24% | — | Stalk |
| Feb 24, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 10,155 | $63.79 | $6.7B | -0.05% | +140.43% | $647.8K | -7.90% | — | Stalk |
| Jan 7, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 7,783 | $74.69 | $6.7B | -0.05% | +140.43% | $581.3K | -9.97% | — | Stalk |
| Jan 7, 2025 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 18,009 | $75.24 | $6.7B | -0.05% | +140.43% | $1.4M | -12.60% | 10b5-1 | Stalk |
| Jan 7, 2025 | Sell | ACLX | Rami Elghandour | — | 30,311 | $74.69 | $6.7B | -0.05% | +140.43% | $2.3M | -9.14% | — | Stalk |
| Jan 3, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 5,950 | $78.36 | $6.7B | -0.05% | +140.43% | $466.2K | -5.91% | — | Stalk |
| Jan 3, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 6,362 | $78.40 | $6.7B | -0.05% | +140.43% | $498.8K | -3.76% | — | Stalk |
| Jan 3, 2025 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 6,362 | $78.40 | $6.7B | -0.05% | +140.43% | $498.8K | -3.76% | — | Stalk |
| Jan 3, 2025 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 10,604 | $78.40 | $6.7B | -0.05% | +140.43% | $831.4K | -5.03% | — | Stalk |
| Jan 3, 2025 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 11,243 | $78.36 | $6.7B | -0.05% | +140.43% | $881.0K | -9.95% | — | Stalk |
| Jan 3, 2025 | Sell | ACLX | Rami Elghandour | — | 28,633 | $78.40 | $6.7B | -0.05% | +140.43% | $2.2M | -3.93% | — | Stalk |
| Jan 3, 2025 | Sell | ACLX | Rami Elghandour | — | 30,223 | $78.36 | $6.7B | -0.05% | +140.43% | $2.4M | -6.70% | — | Stalk |
| Nov 15, 2024 | Buy | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 4,761 | $38.33 | $6.7B | -0.05% | +140.43% | $182.5K | +1.53% | 10b5-1 | Stalk |
| Nov 8, 2024 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 19,554 | $66.71 | $6.7B | -0.05% | +140.43% | $1.3M | -4.71% | 10b5-1 | Stalk |
| Sep 17, 2024 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 30,000 | $43.19 | $6.7B | -0.05% | +140.43% | $1.3M | +0.00% | 10b5-1 | Stalk |
| Sep 5, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 6,842 | $42.51 | $6.7B | -0.05% | +140.43% | $290.8K | +0.00% | 10b5-1 | Stalk |
| Sep 3, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 54,902 | $40.15 | $6.7B | -0.05% | +140.43% | $2.2M | +0.00% | 10b5-1 | Stalk |
| Aug 26, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 43,368 | $43.06 | $6.7B | -0.05% | +140.43% | $1.9M | +0.00% | 10b5-1 | Stalk |
| Aug 16, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 10,900 | $35.67 | $6.7B | -0.05% | +140.43% | $388.8K | +0.00% | 10b5-1 | Stalk |
| Aug 1, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 40,000 | $35.68 | $6.7B | -0.05% | +140.43% | $1.4M | +0.00% | 10b5-1 | Stalk |
| Jul 16, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 21,802 | $35.79 | $6.7B | -0.05% | +140.43% | $780.3K | +0.00% | 10b5-1 | Stalk |
| Jul 11, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 10,902 | $33.18 | $6.7B | -0.05% | +140.43% | $361.7K | +0.00% | 10b5-1 | Stalk |
| Jul 1, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 40,000 | $33.66 | $6.7B | -0.05% | +140.43% | $1.3M | +0.00% | 10b5-1 | Stalk |
| Jun 26, 2024 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 12,877 | $53.70 | $6.7B | -0.05% | +140.43% | $691.5K | -47.24% | 10b5-1 | Stalk |
| Jun 12, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 40,000 | $33.33 | $6.7B | -0.05% | +140.43% | $1.3M | +0.00% | 10b5-1 | Stalk |
| May 24, 2024 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 12,121 | $50.71 | $6.7B | -0.05% | +140.43% | $614.7K | -22.31% | — | Stalk |
| May 1, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 36,336 | $28.80 | $6.7B | -0.05% | +140.43% | $1.0M | +0.00% | 10b5-1 | Stalk |
| Apr 1, 2024 | Sell | ACLX | Rami Elghandour | — | 23,086 | $67.09 | $6.7B | -0.05% | +140.43% | $1.5M | -9.55% | 10b5-1 | Stalk |
| Mar 22, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 72,265 | $47.60 | $6.7B | -0.05% | +140.43% | $3.4M | -5.03% | 10b5-1 | Stalk |
| Mar 18, 2024 | Sell | ACLX | Michelle Gilson | CHIEF FINANCIAL OFFICER | 6,825 | $69.34 | $6.7B | -0.05% | +140.43% | $473.3K | -23.67% | 10b5-1 | Stalk |
| Feb 8, 2024 | Sell | ACLX | Christopher Heery | CHIEF MEDICAL OFFICER | 10,111 | $63.33 | $6.7B | -0.05% | +140.43% | $640.4K | -9.14% | — | Stalk |
| Feb 8, 2024 | Sell | ACLX | Rami Elghandour | — | 38,065 | $63.33 | $6.7B | -0.05% | +140.43% | $2.4M | -10.84% | — | Stalk |
| Jan 4, 2024 | Sell | ACLX | Christopher Heery | Chief Medical Officer | 7,598 | $55.27 | $6.7B | -0.05% | +140.43% | $419.9K | -29.85% | — | Stalk |
| Jan 4, 2024 | Sell | ACLX | Michelle Gilson | Chief Financial Officer | 8,514 | $55.27 | $6.7B | -0.05% | +140.43% | $470.6K | -34.30% | — | Stalk |
| Jan 4, 2024 | Sell | ACLX | Rami Elghandour | — | 29,073 | $55.27 | $6.7B | -0.05% | +140.43% | $1.6M | -32.57% | — | Stalk |
| Dec 18, 2023 | Sell | ACLX | Christopher Heery | Chief Medical Officer | 240,000 | $28.22 | $6.7B | -0.05% | +140.43% | $6.8M | +0.00% | — | Stalk |